Literature DB >> 13679635

Mimotopes of tumor-associated T-cell epitopes for cancer vaccines determined with combinatorial peptide libraries.

Tumenjargal Sherev1, Karl-Heinz Wiesmüller, Peter Walden.   

Abstract

Cytotoxic T-cells are the most important effector cells in immune responses against tumors. The identification of tumor-associated epitopes for these cells, therefore, has become a key aspect of the development of cancer vaccines. Here, we describe a new approach to the determination of tumor-associated T-cell epitopes which employs combinatorial peptide libraries with singly defined sequence positions in a randomized context. The analysis of the responses of a T-cell clone to these libraries yields the amino acid constituents of the epitope which can be combined to obtain mimotopes that are suitable as vaccine antigens for the induction of tumor-specific responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679635     DOI: 10.1385/MB:25:1:53

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  22 in total

1.  Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency.

Authors:  B Hemmer; C Pinilla; B Gran; M Vergelli; N Ling; P Conlon; H F McFarland; R Houghten; R Martin
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

2.  A partially modified retro-inverso pseudopeptide modulates the cytokine profile of CTL specific for an influenza virus epitope.

Authors:  M Ostankovitch; G Guichard; F Connan; S Muller; A Chaboissier; J Hoebeke; J Choppin; J P Briand; J G Guillet
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

3.  T-cell epitope mapping by flow cytometry.

Authors:  F Kern; I P Surel; C Brock; B Freistedt; H Radtke; A Scheffold; R Blasczyk; P Reinke; J Schneider-Mergener; A Radbruch; P Walden; H D Volk
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

Review 4.  T-cell epitope determination.

Authors:  P Walden
Journal:  Curr Opin Immunol       Date:  1996-02       Impact factor: 7.486

5.  Determination of T cell epitopes with random peptide libraries.

Authors:  B R Gundlach; K H Wiesmüller; T Junt; S Kienle; G Jung; P Walden
Journal:  J Immunol Methods       Date:  1996-06-10       Impact factor: 2.303

6.  The identification of CD4+ T cell epitopes with dedicated synthetic peptide libraries.

Authors:  H S Hiemstra; G Duinkerken; W E Benckhuijsen; R Amons; R R de Vries; B O Roep; J W Drijfhout
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

7.  Specificity and degeneracy of minor histocompatibility antigen-specific MHC-restricted CTL.

Authors:  B R Gundlach; K H Wiesmüller; T Junt; S Kienle; G Jung; P Walden
Journal:  J Immunol       Date:  1996-05-15       Impact factor: 5.422

8.  Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone.

Authors:  K Udaka; K H Wiesmüller; S Kienle; G Jung; P Walden
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

9.  The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40.

Authors:  O Türeci; U Sahin; I Schobert; M Koslowski; H Scmitt; H J Schild; F Stenner; G Seitz; H G Rammensee; M Pfreundschuh
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

10.  Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes.

Authors:  C Castelli; W J Storkus; M J Maeurer; D M Martin; E C Huang; B N Pramanik; T L Nagabhushan; G Parmiani; M T Lotze
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  2 in total

Review 1.  T cell antigen discovery.

Authors:  Alok V Joglekar; Guideng Li
Journal:  Nat Methods       Date:  2020-07-06       Impact factor: 28.547

2.  Virtual interactomics of proteins from biochemical standpoint.

Authors:  Jaroslav Kubrycht; Karel Sigler; Pavel Souček
Journal:  Mol Biol Int       Date:  2012-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.